These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 36968111)

  • 21. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ELISPOT-Based "Multi-Color FluoroSpot" to Study Type-Specific and Cross-Reactive Responses in Memory B Cells after Dengue and Zika Virus Infections.
    Andrade P; Coloma J; Harris E
    Methods Mol Biol; 2018; 1808():151-163. PubMed ID: 29956181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection.
    Bonheur AN; Thomas S; Soshnick SH; McGibbon E; Dupuis AP; Hull R; Slavinski S; Del Rosso PE; Weiss D; Hunt DT; McCabe ME; Dean AB; Folkerth R; Laib AM; Wong SJ
    BMC Infect Dis; 2021 Aug; 21(1):749. PubMed ID: 34348665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental Zika virus infection in
    Mourya DT; Gokhale MD; Majumdar TD; Yadav PD; Kumar V; Mavale MS
    Indian J Med Res; 2018 Jan; 147(1):88-96. PubMed ID: 29749366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cell-Fusing Agent Virus Reduces Arbovirus Dissemination in Aedes aegypti Mosquitoes
    Baidaliuk A; Miot EF; Lequime S; Moltini-Conclois I; Delaigue F; Dabo S; Dickson LB; Aubry F; Merkling SH; Cao-Lormeau VM; Lambrechts L
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243123
    [No Abstract]   [Full Text] [Related]  

  • 26. Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor.
    Dussupt V; Sankhala RS; Gromowski GD; Donofrio G; De La Barrera RA; Larocca RA; Zaky W; Mendez-Rivera L; Choe M; Davidson E; McCracken MK; Brien JD; Abbink P; Bai H; Bryan AL; Bias CH; Berry IM; Botero N; Cook T; Doria-Rose NA; Escuer AGI; Frimpong JA; Geretz A; Hernandez M; Hollidge BS; Jian N; Kabra K; Leggat DJ; Liu J; Pinto AK; Rutvisuttinunt W; Setliff I; Tran U; Townsley S; Doranz BJ; Rolland M; McDermott AB; Georgiev IS; Thomas R; Robb ML; Eckels KH; Barranco E; Koren M; Smith DR; Jarman RG; George SL; Stephenson KE; Barouch DH; Modjarrad K; Michael NL; Joyce MG; Krebs SJ
    Nat Med; 2020 Feb; 26(2):228-235. PubMed ID: 32015557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.
    Caraballo GI; Rosales R; Viettri M; Castillo JM; Cruz R; Ding S; Greenberg HB; Ludert JE
    J Virol; 2022 Jun; 96(12):e0070422. PubMed ID: 35652656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective and enhancing interactions among dengue viruses 1-4 and Zika virus.
    Katzelnick LC; Bos S; Harris E
    Curr Opin Virol; 2020 Aug; 43():59-70. PubMed ID: 32979816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses.
    Herrera BB; Tsai WY; Brites C; Luz E; Pedroso C; Drexler JF; Wang WK; Kanki PJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dengue and zika seropositivity, burden, endemicity, and cocirculation antibodies in Nigeria.
    Asaga Mac P; Tadele M; Airiohuodion PE; Nisansala T; Zubair S; Aigohbahi J; Anyaike C; Velayudha R; Kroeger A; Panning M
    Ann Med; 2023 Dec; 55(1):652-662. PubMed ID: 37074313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of Envelope Protein Antigens To Serologically Differentiate Zika Virus Infection from Dengue Virus Infection.
    Premkumar L; Collins M; Graham S; Liou GA; Lopez CA; Jadi R; Balmaseda A; Brackbill JA; Dietze R; Camacho E; De Silva AD; Giuberti C; Dos Reis HL; Singh T; Heimsath H; Weiskopf D; Sette A; Osorio JE; Permar SR; Miley MJ; Lazear HM; Harris E; de Silva AM
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29263206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zika convalescent macaques display delayed induction of anamnestic cross-neutralizing antibody responses after dengue infection.
    Valiant WG; Huang YS; Vanlandingham DL; Higgs S; Lewis MG; Mattapallil JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):130. PubMed ID: 30006514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-Reaction, Enhancement, and Neutralization Activity of Dengue Virus Antibodies against Zika Virus: A Study in the Mexican Population.
    Montecillo-Aguado MR; Montes-Gómez AE; García-Cordero J; Corzo-Gómez J; Vivanco-Cid H; Mellado-Sánchez G; Muñoz-Medina JE; Gutiérrez-Castañeda B; Santos-Argumedo L; González-Bonilla C; Cedillo-Barrón L
    J Immunol Res; 2019; 2019():7239347. PubMed ID: 31565661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dengue virus envelope protein domain III-elicited antibodies mediate cross-protection against Zika virus in a mouse model.
    Zhou Y; Chen D; Yang L; Zou W; Duan Z; Zhang Y; Wen J
    Virus Res; 2020 Mar; 278():197882. PubMed ID: 31981774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4
    Wen J; Wang YT; Valentine KM; Dos Santos Alves RP; Xu Z; Regla-Nava JA; Ngono AE; Young MP; Ferreira LCS; Shresta S
    Cell Rep; 2020 Apr; 31(4):107566. PubMed ID: 32348763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.
    Adam A; Woda M; Kounlavouth S; Rothman AL; Jarman RG; Cox JH; Ledgerwood JE; Gromowski GD; Currier JR; Friberg H; Mathew A
    J Immunol; 2018 Dec; 201(12):3804-3814. PubMed ID: 30413671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology.
    Priyamvada L; Hudson W; Ahmed R; Wrammert J
    Emerg Microbes Infect; 2017 May; 6(5):e33. PubMed ID: 28487557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preexisting inter-serotype immunity drives antigenic evolution of dengue virus serotype 2.
    Marano JM; Weger-Lucarelli J
    Virology; 2024 Feb; 590():109951. PubMed ID: 38096749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological tests reveal significant cross-reactive human antibody responses to Zika and Dengue viruses in the Mexican population.
    Zaidi MB; Cedillo-Barron L; González Y Almeida ME; Garcia-Cordero J; Campos FD; Namorado-Tonix K; Perez F
    Acta Trop; 2020 Jan; 201():105201. PubMed ID: 31562846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.